Variable cognitive benefits in HAART-treated patients: are aging and low cholesterol linked?

References

• Minagar A, Commins D, Alexander JS, et al. NeuroAIDS: characteristics and diagnosis of the neurological complications of AIDS.(Neurological Disorders). Mol Diagn Ther. 2008;12(1):25–43.
   Web of Science ®Google Scholar
• AntinoriA,Arendt G, Becker JT, et al. Updated research nosology for HIV-associated neurocognitive disorders. Neurology. 2007;69:1789–1799.
   Web of Science ®Google Scholar
• Valenza M, Cattaneo E. Cholesterol dysfunction in neurodegenerative diseases: is Huntington’s disease in the list? Prog Neurobiol. 2006;80(4):165–176.
   PubMed Web of Science ®Google Scholar
• Merched A, Xia Y, Visvikis S, Serot JM, Siest G. Decreased high-density lipoprotein cholesterol and serum apolipoprotein A-I concentrations are highly correlated with the severity of Alzheimer’s disease. Neurobiol Aging. 2000;21:27–30.
   PubMed Web of Science ®Google Scholar
• Park IH, Hwang E, Hong H, et al. Lovastatin enhances Abeta production and senile plaque deposition in female Tg2576 mice. Neurobiol Aging. 2003;24:637–643.
   PubMed Web of Science ®Google Scholar
• Crook M. The basis and management of metabolic abnormalities associated with cardiovascular risk in human immunodeficiency virus infection and its treatment. Ann Clin Biochem. 2007;44:219–231.
   Web of Science ®Google Scholar
• Porter FD. RSH/Smith-Lemli-Opitz syndrome: a multiple congenital anomaly/mental retardation syndrome due to an inborn error of cholesterol biosynthesis. Mol Genet Metab. 2000;71:163–174.
   Web of Science ®Google Scholar
• Reitz C, Tang MX, Luchsinger J, Mayeux R. Relation of plasma lipids to Alzheimer disease and vascular dementia. Arch Neurol. 2004;61:705–714.
   PubMed Web of Science ®Google Scholar
• Mielke MM, Zandi PP, Sjogren M, et al. High total cholesterol levels in late life associated with a reduced risk of dementia. Neurology. 2005;64:1689–1695.
   PubMed Web of Science ®Google Scholar
• Kuusisto J, Koivisto K, Mykkänen L, et al. Association between features of the insulin resistance syndrome and Alzheimer’s disease independently of apolipoprotein E4 phenotype: cross sectional population based study. BMJ. 1997;315:1045–049.
   PubMed Web of Science ®Google Scholar
• Scacchi R, De Bernardini L, Mantuano E, et al. DNA polymorphisms of apolipoprotein B and angiotensin I-converting enzyme genes and relationships with lipid levels in Italian patients with vascular dementia or Alzheimer’s disease. Dement Geriatr Cogn Disord. 1998;9(4):186–190.
   Web of Science ®Google Scholar
• Shor-Posner G, Feaster D, Baldewicz T, Blaney, NT, et al. Psychological distress in HIV-1 disease in relationship to hypocholesterolemia. Int’l J of Psychiat in Med. 1997;27(2):159–171.
   Web of Science ®Google Scholar
• Valcour V, Shikuma C, Shiramizu B, et al. Higher frequency of dementia in older HIV-1 individuals: the hawaii aging with HIV-1 cohort. Neurology. 2004;63:822–827.
   PubMed Web of Science ®Google Scholar
• Goodkin K, Wilkie FL, Concha M, et al. Aging and neuro-AIDS conditions: a potential interaction with the changing spectrum of HIV-1 associated morbidity and mortality in the era of HAART? J Clin Epidemiol. 2001;54:S35–S43.
   PubMed Web of Science ®Google Scholar
• Goodkin K, Concha M, Jamieson BD, et al. Interaction of the aging process with neurobehavioral and neuro-AIDS conditions in the HAART era. In: Goodkin K, Shapshak P, Verma A, editors. Neuro-AIDS in the HAART Era: Pathophysiology, Diagnosis and Treatment. Washington, DC: American Society for Microbiology Press; 2009:473–486.
   Google Scholar
• Pereda M, Ayuso-Mateos JL, Gomez Del Barrio A, et al. Factors associated with neuropsychological performance in HIV-seropositive subjects without AIDS. Psychol Med. 2000;30:205–217.
   PubMed Web of Science ®Google Scholar
• Van Gorp WG, Miller EN, Marcotte TD, et al. The relationship between age and cognitive impairment in HIV-1 infection: findings from the multicenter AIDS cohort study and a clinical cohort. Neurol. 1994;44:929–935.
   PubMed Web of Science ®Google Scholar
• Kissel E, Pukay-Martin N, Bornstein R. The relationship between age and cognitive function in HIV-infected men. J Neuropsychiatry Clin Neurosci. 2005;17:180–184.
   PubMed Web of Science ®Google Scholar
• Vance D, Ross L, Downs Ch. Self-reported cognitive ability and global cognitive performance in adults with HIV. The Journal of Neuroscience Nursing. 2008 May. http://www.medscape.com/viewarticle/571448. Accessed July 15, 2009.
   Google Scholar
• DHHS/Henry J Kaiser Family Foundation Panel on clinical practices for the treatment of HIV infection. Guidelines for the use of antiretroviral agents in HIV-infected adults and adolescents. Updated May 2006. Available from: http://aidsinfo.nih.gov/ContentFiles/AdultandAdolescentGL05042006050.pdf. Accessed July 10, 2009.
   Google Scholar
• Grundy SM, Cleeman JI, Merz CN, et al. US national cholesterol guidelines implications of recent clinical trials for the national cholesterol education program adult treatment panel III guidelines. Coordinating Committee of the National Cholesterol Education Program; National Heart, Lung, and Blood Institute; American College of Cardiology Foundation; American Heart Association. Arterioscler Thromb Vasc Biol. 2004;24:e149–e161.
   PubMed Web of Science ®Google Scholar
• Delis DC, Kramer JH, Kaplan E, Ober BA.. California Verbal Learning Test, New York, NY: The Psychological Corporation; 1987.
   Google Scholar
• Goodkin K, Hardy DJ, Lopez E, et al. Performance of screening tests for HIV-associated neurocognitive disorder risk in an Argentinean sample. In: Abstracts of the Third NIMH Meeting on HIV Infection and the Central Nervous System. Stresa – Lago Maggiore, Italy, October, 22–24, 2009.
   Google Scholar
• Goodkin K, Cahn P, Concha C, Abusamra L, Lopez E, Kogan J. Prevalence of HIV-1-associated neurocognitive disorders in Argentina. In: Abstracts of the 5TH IAS Conference on HIV Pathogenesis, Treatment and Prevention July 19–22, 2009, Cape Town, South Africa, #MOPEB028.
   Google Scholar
• Lopez E, Morales G, and Goodkin K.. “Hispano”: Una consideracion del termino para trastornos cognitivos en VIH. (Spanish). Actualizaciones en SIDA. 2009;17(65):95–103.
   Google Scholar
• Power C, Selnes OA, Grim JA, McArthur JC. The HIV Dementia Scale: A rapid screening test. J AIDS. 1995;8:273–278.
   Web of Science ®Google Scholar
• Dougherty RH, Skolasky RL, McArthur JC. Progression of HIV-associated dementia treated with HAART. AIDS Read. 2002;12: 69–74.
   PubMedGoogle Scholar
• Smith CA, van Gorp WG, Ryan ER, et al. Screening subtle HIV-related cognitive dysfunction: The clinical utility of the HIV Dementia Scale. J Acquir Immune Defic Syndr. 2003;33:116–118.
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Recomm Rep. 1992 Dec 18;41(RR–17):1–19. Available online at www.cdc.gov/mmwr/preview/mmwrhtml/00018871.htm. Accessed June 29, 2009.
   Google Scholar
• Global Health Delivery Project. ACTG adherence baseline and followup questionnaires. May 2009. Available from http://www.ghdonline.org/adherence/resource/actg-adherence-baseline-and-follow-upquestionnair/. Accessed July 13, 2009.
   Google Scholar
• Míguez-Burbano MJ, Lewis JE, Fishman J, et al. The influence of different types of alcoholic beverages on disrupting HAART. Alcohol Alcohol. 2009;44(4):366–371.
   PubMed Web of Science ®Google Scholar
• Stewart R, White L, Xue Q, Launer L. Twenty-six–year change in total cholesterol levels and incident dementia: The Honolulu-Asia aging study. Arch Neurol. 2007;64:103–107.
   PubMed Web of Science ®Google Scholar
• Penelope E, Elias M, D’Agostino R, Sullivan L, Wolf P. Serum cholesterol and cognitive performance in the Framingham Heart Study. Psychosom Med. 2005;67:24–30.
   Web of Science ®Google Scholar
• Romas SN, Tang MX, Berglund L, Mayeux R. APOE genotype, plasma lipids, lipoproteins, and AD in community elderly. Neurology. 1999;53:517–521.
   PubMed Web of Science ®Google Scholar
• Panzaa F, Solfrizzia V, D’Intronoa A, et al. Higher total cholesterol, cognitive decline, and dementia. Neurobiol Aging. 2009;30(4): 546–548.
   Web of Science ®Google Scholar
• Barefoot J, Grønbæk M, Feaganes J, et al Alcoholic beverage preference, diet, and health habits in the UNC Alumni Heart Study. Am J Clin Nutr. 2002;76:466–472.
   PubMed Web of Science ®Google Scholar
• Stoff DM, Khalsa JH, Monjan A, Portegies P. Introduction: HIV/AIDS and aging. Aids. 2004;18 Suppl 1:S1–S2.
   Google Scholar
• Mujawar Z, Rose H, Morrow MP, Pushkarsky T, Dubrovsky L, et al. Human immunodeficiency virus impairs reverse cholesterol transport from macrophages. PLoS Biol. 2006;4(11):e365.
   PubMed Web of Science ®Google Scholar
• Gross L. HIV–Cholesterol connection suggests a new antiretroviral strategy. PLoS Biol. 2006;4(11):e375–e400.
   Google Scholar
• Verma SP. HIV: a raft-targeting approach for prevention and therapy using plant derived compounds (review). Curr Drug Targets. 2009;10(1):51–59.
   Web of Science ®Google Scholar
• Tang Y, Leao IC, Coleman EM, Broughton RS, Hildreth JE. Deficiency of Niemann-Pick type C-1 protein impairs HIV-1 release and results in gag accumulation in late endosomal/lysosomal compartments. J Virol. 2009;83(16):7982–7995.
   PubMed Web of Science ®Google Scholar
• Rose H, Hoy J, Woolley I, et al. HIV infection and high density lipoprotein metabolism. Atherosclerosis. 2008;199(1):79–86.
   Web of Science ®Google Scholar